Medabon 200 mg + 0,2 mg comprimate + comprimate vaginale Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

medabon 200 mg + 0,2 mg comprimate + comprimate vaginale

sun pharmaceutical industries ltd. - mifepristonum + misoprostolum - comprimate + comprimate vaginale - 200 mg + 0,2 mg

Medabon 200 mg; 0,2 mg comprimate; comprimate vaginale Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

medabon 200 mg; 0,2 mg comprimate; comprimate vaginale

sun pharmaceutical industries, ltd - mifepristonum + misoprostolum - comprimate; comprimate vaginale - 200 mg; 0,2 mg

ESMYA România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

esmya

cenexi - franta - ulipristalum acetatum - compr. - 5mg - alti hormoni sexuali si modulatori ai aparatului genital antiprogestative

Xevudy Uniunea Europeană - română - EMA (European Medicines Agency)

xevudy

glaxosmithkline trading services limited - sotrovimab - covid-19 virus infection - seruri imune și imunoglobuline, - xevudy is indicated for the treatment of adults and adolescents (aged 12 years and over and weighing at least 40 kg) with coronavirus disease 2019 (covid-19) who do not require oxygen supplementation and who are at increased risk of progressing to severe covid-19.

GEMCITABINA KABI 38 mg/ml România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

gemcitabina kabi 38 mg/ml

fresenius kabi oncology plc. - gemcitabinum - conc. pt. sol. perf. - 38mg/ml - antimetaboliti analogi ai bazelor pirimidinice

Veklury Uniunea Europeană - română - EMA (European Medicines Agency)

veklury

gilead sciences ireland uc - remdesivir - covid-19 virus infection - veklury is indicated for the treatment of coronavirus disease 2019 (covid 19) in:adults and paediatric patients (at least 4 weeks of age and weighing at least 3 kg) with pneumonia requiring supplemental oxygen (low- or high-flow oxygen or other non-invasive ventilation at start of treatment)adults and paediatric patients (weighing at least 40 kg) who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19.